A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Clinical trial NCT05396391 · UNKNOWN

Trial details

NCT number: NCT05396391
Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2022-06-22
Primary completion: 2024-05-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.